2016-07-07 10:15:25 CEST

2016-07-07 10:15:25 CEST


BIRTINGARSKYLDAR UPPLÝSNINGAR

Enska Finnska
Okmetic Oyj - Company Announcement

Final result of the subsequent offer period of NSIG Finland's voluntary public tender offer for all the shares and option rights in Okmetic



OKMETIC OYJ            STOCK EXCHANGE RELEASE                   7 JULY 2016
    AT 11.15 A.M.


NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN
OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, CANADA,
JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN
WHICH THE TENDER OFFER OR SUCH RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY
APPLICABLE LAW OR REQUIRE OFFER DOCUMENTS, REGISTRATION OR OTHER MEASURES IN
ADDITION TO THOSE REQUIRED UNDER FINNISH LAW.

FINAL RESULT OF THE SUBSEQUENT OFFER PERIOD OF NSIG FINLAND'S VOLUNTARY PUBLIC
TENDER OFFER FOR ALL THE SHARES AND OPTION RIGHTS IN OKMETIC

NSIG Finland S.à r.l. ("NSIG Finland"), a wholly-owned indirect subsidiary of
National Silicon Industry Group ("NSIG"), has made a voluntary public tender
offer to purchase all of the issued and outstanding shares and option rights in
Okmetic Oyj ("Okmetic") that are not owned by Okmetic or any of its subsidiaries
(the "Tender Offer"). The subsequent offer period under the Tender Offer
commenced on 20 June 2016 and expired on 4 July 2016 (the "Subsequent Offer
Period").

NSIG has today on 7 July 2016 published a press release, according to which

  * According to the final result of the Subsequent Offer Period, the shares
    tendered during the Subsequent Offer Period represent approximately 0.63 per
    cent of all the shares and votes in Okmetic (excluding the treasury shares
    held by Okmetic). No option rights were tendered during the Subsequent Offer
    Period. Together with the shares tendered during the actual offer period,
    the shares tendered in the Tender Offer represent approximately 96.41 per
    cent of all the shares and votes in Okmetic (excluding the treasury shares
    held by Okmetic).

  * Taking into account shares acquired through open market purchases, NSIG
    Finland will hold approximately 96.78 percent of all the shares and votes in
    Okmetic (excluding the treasury shares held by Okmetic) after the settlement
    of the sale and purchase of the shares tendered during the Subsequent Offer
    Period. Together with the option rights that were tendered in the Tender
    Offer during the actual offer period (the approximately 98.52 per cent of
    the option rights), this implies a holding of approximately 96.72 per cent
    of all the shares and votes in Okmetic fully diluted for the outstanding
    option rights and excluding the treasury shares held by Okmetic.

  * The sale and purchase of the shares validly tendered during the Subsequent
    Offer Period will be executed on or about 8 July 2016 and settlement will be
    effected on or about 12 July 2016 (the "Settlement Date").

  * The offer consideration for the shares validly tendered during the
    Subsequent Offer Period will be paid on the Settlement Date into the bank
    account connected to the book-entry account of the shareholder or, in the
    case of nominee-registered shares, into the bank account specified in the
    acceptance form. Actual time of receipt for the payment by the shareholder
    will depend on the schedules of money transactions between financial
    institutions and agreements between the holder and account operator,
    custodian or nominee in each case.

  * NSIG Finland's intention is to acquire all the shares and option rights in
    Okmetic. As NSIG Finland's ownership in Okmetic has exceeded nine-tenths
    (9/10) of the shares and votes in Okmetic through the Tender Offer, NSIG
    Finland has filed an application with the Redemption Committee of the
    Finland Chamber of Commerce to initiate compulsory redemption proceedings
    for the remaining Okmetic shares under the Finnish Companies Act.

  * NSIG Finland may purchase shares and option rights in Okmetic also in public
    trading on Nasdaq Helsinki or otherwise at a price not exceeding the offer
    price of EUR 9.20 per share and at a price not exceeding the offer price for
    the option rights as follows: EUR 4.87 for each 2013 A option right and EUR
    4.62 for each 2013 B option right.


The press release of NSIG referred to above is attached in its entirety as Annex
1 to this stock exchange release.

OKMETIC OYJ

Board of Directors

For further information, please contact:

President Kai Seikku
Phone: +358 9 5028 0232, e-mail: kai.seikku@okmetic.com

INFORMATION REGARDING OKMETIC OYJ

Established in 1985, Okmetic is one of the leading specialty silicon wafers
producers and suppliers globally with a production plant in Vantaa, Finland, and
contract manufacturers in China and Japan. The Company has sales offices in
Japan, Hong Kong and the United States as well as a diverse network of agents,
serving customers in China, South Korea, Malaysia, Singapore, Taiwan and the
United States. The tailored, high value-added silicon wafers of Okmetic are used
in the manufacture of sensors as well as discrete semiconductors and analog
circuits. Okmetic is listed on the official list of Nasdaq Helsinki (trading
code OKM1V).

Okmetic's head office is located in Vantaa. For more information visit
www.okmetic.com.

INFORMATION REGARDING NSIG

NSIG is a limited liability company organized under the PRC laws. The registered
office of NSIG is in Shanghai, China.

Established in 2015, NSIG is a China-based holding group that is engaged in the
investment and development of semiconductor materials and equipment industry
with a registered capital of RMB 2 billion (approximately EUR 272 million).
NSIG's mission is to establish a major industrial player in the global
semiconductor sector (especially silicon and its ecosystems) through both PRC
domestic investments and outbound mergers and acquisitions.

DISCLAIMER

THIS RELEASE IS FOR GENERAL INFORMATION ONLY AND DOES NOT CONSTITUTE OR FORM
PART OF ANY OFFER TO PURCHASE, OR ANY SOLICITATION OF AN OFFER TO SELL OR ANY
INVITATION TO PARTICIPATE. INVESTORS MAY ACCEPT THE TENDER OFFER FOR THE SHARES
AND OPTION RIGHTS ONLY ON THE BASIS OF THE INFORMATION PROVIDED IN A TENDER
OFFER DOCUMENT.

THE TENDER OFFER FOR THE SHARES AND OPTION RIGHTS IS NOT BEING AND WILL NOT BE
MADE DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE THE MAKING OF SUCH AN
OFFER OR PARTICIPATION THEREIN IS PROHIBITED BY APPLICABLE LAW OR WHICH WOULD
REQUIRE FURTHER OFFER DOCUMENTS, REGISTRATION OR OTHER MEASURES IN ADDITION TO
THOSE REQUIRED UNDER FINNISH LAW.

ACCORDINGLY, THE TENDER OFFER DOCUMENT AND RELATED ACCEPTANCE FORMS WILL NOT AND
MAY NOT BE DISTRIBUTED, FORWARDED OR TRANSMITTED INTO OR FROM ANY JURISDICTION
WHERE PROHIBITED BY APPLICABLE LAW OR WHICH WOULD REQUIRE FURTHER OFFER
DOCUMENTS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER
FINNISH LAW. IN PARTICULAR, THE TENDER OFFER FOR THE SHARES AND OPTION RIGHTS IS
NOT BEING AND WILL NOT BE MADE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR BY USE OF
THE POSTAL SERVICE OF, OR BY ANY MEANS OR INSTRUMENTALITY (INCLUDING, WITHOUT
LIMITATION, FACSIMILE TRANSMISSION, TELEX, TELEPHONE, E-,MAIL OR OTHER FORMS OF
ELECTRONIC COMMUNICATION) OF INTERSTATE OR FOREIGN COMMERCE OF, OR ANY
FACILITIES OF A NATIONAL SECURITIES EXCHANGE OF, THE UNITED STATES, CANADA,
JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG, AND MAY NOT BE ACCEPTED BY ANY SUCH
USE, MEANS, INSTRUMENTALITY OR FACILITY FROM OR WITHIN THE UNITED STATES,
CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR BY PERSONS LOCATED OR
RESIDENT THEREIN, OR PERSONS (INCLUDING AGENTS, FIDUCIARIES OR OTHER
INTERMEDIARIES) ACTING FOR THE ACCOUNT OR BENEFIT OF PERSONS LOCATED OR RESIDENT
THEREIN. ANY PURPORTED ACCEPTANCE OF THE TENDER OFFER FOR THE SHARES AND OPTION
RIGHTS RESULTING DIRECTLY OR INDIRECTLY FROM A VIOLATION OF THESE RESTRICTIONS
WILL BE INVALID.

THE COMMUNICATION OF THIS ANNOUNCEMENT, THE TENDER OFFER DOCUMENT AND ANY OTHER
DOCUMENTS OR MATERIALS RELATING TO THE TENDER OFFER IS NOT BEING MADE AND SUCH
DOCUMENTS AND/OR MATERIALS HAVE NOT BEEN APPROVED BY AN AUTHORISED PERSON FOR
THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 OF THE
UNITED KINGDOM. ACCORDINGLY, SUCH DOCUMENTS AND/OR MATERIALS ARE NOT BEING
DISTRIBUTED TO, AND MUST NOT BE PASSED ON TO, THE GENERAL PUBLIC IN THE UNITED
KINGDOM. THE COMMUNICATION OF SUCH DOCUMENTS AND/OR MATERIALS AS A FINANCIAL
PROMOTION IS ONLY BEING MADE TO THOSE PERSONS IN THE UNITED KINGDOM FALLING
WITHIN THE DEFINITION OF INVESTMENT PROFESSIONALS (AS DEFINED IN ARTICLE 19(5)
OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005
(THE "FINANCIAL PROMOTION ORDER")) OR PERSONS WHO ARE WITHIN ARTICLE 43 OF THE
FINANCIAL PROMOTION ORDER OR ANY OTHER PERSONS TO WHOM IT MAY OTHERWISE LAWFULLY
BE MADE UNDER THE FINANCIAL PROMOTION ORDER.

UBS Limited is authorised by the Prudential Regulation Authority and regulated
by the Financial Conduct Authority and the Prudential Regulation Authority in
the United Kingdom. UBS Limited is acting as financial adviser to Okmetic and no
one else in connection with the Tender Offer and will not be responsible to
anyone other than Okmetic for providing the protections offered to clients of
UBS Limited nor for providing advice in connection with the Tender Offer.

ANNEX 1: Press release of National Silicon Industry Group on 7 July 2016

FINAL RESULT OF THE SUBSEQUENT OFFER PERIOD OF NSIG FINLAND'S TENDER OFFER FOR
ALL THE SHARES AND OPTION RIGHTS IN OKMETIC

NATIONAL SILICON INDUSTRY GROUP PRESS RELEASE                     7 July 2016 at
11:00 am

NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN
OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, CANADA,
JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN
WHICH THE TENDER OFFER OR SUCH RELEASE OR DISTRIBUTION WOULD BE PROHIBITED BY
APPLICABLE LAW OR REQUIRE OFFER DOCUMENTS, REGISTRATION OR OTHER MEASURES IN
ADDITION TO THOSE REQUIRED UNDER FINNISH LAW.

FINAL RESULT OF THE SUBSEQUENT OFFER PERIOD OF NSIG FINLAND'S TENDER OFFER FOR
ALL THE SHARES AND OPTION RIGHTS IN OKMETIC

NSIG Finland S.à r.l. ("NSIG Finland" or the "Offeror"), a wholly-owned indirect
subsidiary of National Silicon Industry Group ("NSIG"), commenced on 22 April
2016 a voluntary public tender offer to purchase all of the issued and
outstanding shares and option rights in Okmetic Oyj ("Okmetic") that are not
owned by Okmetic or any of its subsidiaries (the "Tender Offer"). The subsequent
offer period under the Tender Offer commenced on 20 June 2016 and expired on 4
July 2016 (the "Subsequent Offer Period").

According to the final result of the Subsequent Offer Period, the shares
tendered during the Subsequent Offer Period represent approximately 0.63 per
cent of all the shares and votes in Okmetic (excluding the treasury shares held
by Okmetic). No option rights were tendered during the Subsequent Offer Period.
Together with the shares tendered during the actual offer period, the shares
tendered in the Tender Offer represent approximately 96.41 per cent of all the
shares and votes in Okmetic (excluding the treasury shares held by Okmetic).

Taking into account shares acquired through open market purchases, the Offeror
will hold approximately 96.78 percent of all the shares and votes in Okmetic
(excluding the treasury shares held by Okmetic) after the settlement of the sale
and purchase of the shares tendered during the Subsequent Offer Period. Together
with the option rights that were tendered in the Tender Offer during the actual
offer period (approximately 98.52 per cent of the option rights), this implies a
holding of approximately 96.72 per cent of all the shares and votes in Okmetic
fully diluted for the outstanding option rights and excluding the treasury
shares held by Okmetic.

The sale and purchase of the shares validly tendered during the Subsequent Offer
Period will be executed on or about 8 July 2016 and settlement will be effected
on or about 12 July 2016 (the "Settlement Date").

The offer consideration for the shares validly tendered during the Subsequent
Offer Period will be paid on the Settlement Date into the bank account connected
to the book-entry account of the shareholder or, in the case of nominee-
registered shares, into the bank account specified in the acceptance form.
Actual time of receipt for the payment by the shareholder will depend on the
schedules of money transactions between financial institutions and agreements
between the holder and account operator, custodian or nominee in each case.

The Offeror's intention is to acquire all the shares and option rights in
Okmetic. As the Offeror's ownership in Okmetic has exceeded nine-tenths (9/10)
of the shares and votes in Okmetic through the Tender Offer, the Offeror has
filed an application with the Redemption Committee of the Finland Chamber of
Commerce to initiate compulsory redemption proceedings for the remaining Okmetic
shares under the Finnish Companies Act.

The Offeror may purchase shares and option rights in Okmetic also in public
trading on Nasdaq Helsinki or otherwise at a price not exceeding the offer price
of EUR 9.20 per share and at a price not exceeding the offer price for the
option rights as follows: EUR 4.87 for each 2013 A option right and EUR 4.62 for
each 2013 B option right.

7]July 2016

National Silicon Industry Group                   NSIG Finland S.à r.l.

For further information, please contact:

NSIG

Managing Director Leo Ren
Phone: +86 21 5285 9096, e-mail: leoren@sh-nsig.com

INFORMATION REGARDING NSIG

NSIG is a limited liability company organized under the PRC laws. The registered
office of NSIG is in Shanghai, China.

Established in 2015, National Silicon Industry Group is a China-based holding
group that is engaged in the investment and development of semiconductor
materials and equipment industry with a registered capital of RMB 2 billion
(approximately EUR 272 million). NSIG's mission is to establish a major
industrial player in the global semiconductor sector (especially silicon and its
ecosystems) through both PRC domestic investments and outbound mergers and
acquisitions.

INFORMATION REGARDING OKMETIC OYJ

Established in 1985, Okmetic is one of the leading specialty silicon wafers
producers and suppliers globally with a production plant in Vantaa, Finland, and
contract manufacturers in China and Japan. The Company has sales offices in
Japan, Hong Kong and the United States as well as a diverse network of agents,
serving customers in China, South Korea, Malaysia, Singapore, Taiwan and the
United States. The tailored, high value-added silicon wafers of Okmetic are used
in the manufacture of sensors as well as discrete semiconductors and analog
circuits. Okmetic is listed on the official list of Nasdaq Helsinki (trading
code: OKM1V).

Okmetic's head office is located in Vantaa. For more information visit
www.okmetic.com.

DISCLAIMER

THIS RELEASE IS FOR GENERAL INFORMATION ONLY AND DOES NOT CONSTITUTE OR FORM
PART OF ANY OFFER TO PURCHASE, OR ANY SOLICITATION OF AN OFFER TO SELL OR ANY
INVITATION TO PARTICIPATE. INVESTORS MAY ACCEPT THE TENDER OFFER FOR THE SHARES
AND OPTION RIGHTS ONLY ON THE BASIS OF THE INFORMATION PROVIDED IN A TENDER
OFFER DOCUMENT.

THE TENDER OFFER FOR THE SHARES AND OPTION RIGHTS IS NOT BEING AND WILL NOT BE
MADE DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE THE MAKING OF SUCH AN
OFFER OR PARTICIPATION THEREIN IS PROHIBITED BY APPLICABLE LAW OR WHICH WOULD
REQUIRE FURTHER OFFER DOCUMENTS, REGISTRATION OR OTHER MEASURES IN ADDITION TO
THOSE REQUIRED UNDER FINNISH LAW.

ACCORDINGLY, THE TENDER OFFER DOCUMENT AND RELATED ACCEPTANCE FORMS WILL NOT AND
MAY NOT BE DISTRIBUTED, FORWARDED OR TRANSMITTED INTO OR FROM ANY JURISDICTION
WHERE PROHIBITED BY APPLICABLE LAW OR WHICH WOULD REQUIRE FURTHER OFFER
DOCUMENTS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER
FINNISH LAW. IN PARTICULAR, THE TENDER OFFER FOR THE SHARES AND OPTION RIGHTS IS
NOT BEING AND WILL NOT BE MADE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR BY USE OF
THE POSTAL SERVICE OF, OR BY ANY MEANS OR INSTRUMENTALITY (INCLUDING, WITHOUT
LIMITATION, FACSIMILE TRANSMISSION, TELEX, TELEPHONE, E-,MAIL OR OTHER FORMS OF
ELECTRONIC COMMUNICATION) OF INTERSTATE OR FOREIGN COMMERCE OF, OR ANY
FACILITIES OF A NATIONAL SECURITIES EXCHANGE OF, THE UNITED STATES, CANADA,
JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG, AND MAY NOT BE ACCEPTED BY ANY SUCH
USE, MEANS, INSTRUMENTALITY OR FACILITY FROM OR WITHIN THE UNITED STATES,
CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR BY PERSONS LOCATED OR
RESIDENT THEREIN, OR PERSONS (INCLUDING AGENTS, FIDUCIARIES OR OTHER
INTERMEDIARIES) ACTING FOR THE ACCOUNT OR BENEFIT OF PERSONS LOCATED OR RESIDENT
THEREIN. ANY PURPORTED ACCEPTANCE OF THE TENDER OFFER FOR THE SHARES AND OPTION
RIGHTS RESULTING DIRECTLY OR INDIRECTLY FROM A VIOLATION OF THESE RESTRICTIONS
WILL BE INVALID.

THE COMMUNICATION OF THIS ANNOUNCEMENT, THE TENDER OFFER DOCUMENT AND ANY OTHER
DOCUMENTS OR MATERIALS RELATING TO THE TENDER OFFER IS NOT BEING MADE AND SUCH
DOCUMENTS AND/OR MATERIALS HAVE NOT BEEN APPROVED BY AN AUTHORISED PERSON FOR
THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 OF THE
UNITED KINGDOM. ACCORDINGLY, SUCH DOCUMENTS AND/OR MATERIALS ARE NOT BEING
DISTRIBUTED TO, AND MUST NOT BE PASSED ON TO, THE GENERAL PUBLIC IN THE UNITED
KINGDOM. THE COMMUNICATION OF SUCH DOCUMENTS AND/OR MATERIALS AS A FINANCIAL
PROMOTION IS ONLY BEING MADE TO THOSE PERSONS IN THE UNITED KINGDOM FALLING
WITHIN THE DEFINITION OF INVESTMENT PROFESSIONALS (AS DEFINED IN ARTICLE 19(5)
OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005
(THE "FINANCIAL PROMOTION ORDER")) OR PERSONS WHO ARE WITHIN ARTICLE 43 OF THE
FINANCIAL PROMOTION ORDER OR ANY OTHER PERSONS TO WHOM IT MAY OTHERWISE LAWFULLY
BE MADE UNDER THE FINANCIAL PROMOTION ORDER.

UBS Limited is authorised by the Prudential Regulation Authority and regulated
by the Financial Conduct Authority and the Prudential Regulation Authority in
the United Kingdom. UBS Limited is acting as financial adviser to Okmetic and no
one else in connection with the Tender Offer and will not be responsible to
anyone other than Okmetic for providing the protections offered to clients of
UBS Limited nor for providing advice in connection with the Tender Offer.


[HUG#2026802]